Claymount Group

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Claymount Group - overview

Established

1984

Location

-, -, Netherlands

Primary Industry

Medical Devices & Equipment

About

Claymount Group is a specialist in designing and manufacturing high voltage connections, serving various industries including medical, industrial, and scientific X-ray applications with a focus on reliability and innovative engineering. Claymount Group was founded in 1984 in the Netherlands. The company specializes in high voltage connections tailored for medical and industrial applications, without known major pivots in its operations. The firm's recent history includes two significant deals, with the most recent transaction occurring on October 1, 2010, when GIMV sold its 42.


5% stake to QSolid B. V. Claymount Group's core offerings include specialized high voltage cables, connectors, and receptacles designed for demanding applications in healthcare, security systems, and industrial sectors. Their products are recognized for quality and reliability, facilitating integration into critical systems such as X-ray machines, with a customer base spanning North America, Europe, and Asia.


For the year 2022, Claymount Group reported a revenue of USD 65. 16 mn and an EBITDA of USD 12. 00 mn, driven primarily by direct sales to OEMs and distributors for their high voltage connections. Looking ahead, Claymount Group plans to expand its product line, focusing on the development of advanced high voltage connections aimed at new healthcare technologies.


Geographically, they are targeting expansion into Asian markets by 2025, aiming to establish partnerships with local distributors. Recent funding from their last deal in 2010 will be strategically utilized to support these growth initiatives and further enhance product offerings.


Primary Industry

Medical Devices & Equipment

Sub Industries

Monitoring Equipment

Website

www.claymount.com

Verticals

HealthTech, Manufacturing

Company Stage

Acquired

Total Amount Raised

Subscriber access only

Claymount Group - financials

Fiscal Year EndedSep 29, 2017Sep 28, 2018Sep 27, 2019Oct 02, 2020Oct 01, 2021Sep 30, 2022
Revenue (USD)33,188,310-47,632,000---
% Revenue Growth (YoY)------
EBITDA (USD)8,169,6328,504,4908,422,000---
Operating Income (USD)6,625,8696,616,1206,670,000---
Operating Margin20.0%-14.0%---
% EBITDA Margin24.6%-17.7%---
NET Income (USD)6,970,7285,408,5535,097,000---
% Net Margin21.0%-10.7%---

Claymount Group - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Trade SaleCompletedVarian Medical Systems, Inc.-
Trade SaleCompletedClaymount Group-
BuyoutCompletedClaymount Group-

Displaying 1 - 3 of 3

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.